Similar Posts
SMC reject donanemab for use in NHS in Scotland
The Scottish Medicines Consortium (SMC) has rejected new Alzheimer’s drug, donanemab, for use in the NHS in Scotland. This aligns with the view of NICE (which we covered here https://journalofdementiacare.co.uk/nice-publish-further-draft-guidance-on-lecanemab-and-donanemab) when considering donanemab (and lecanemab) for use in the NHS in England and Wales. The reasons given by the SMC are similar to NICE. Anyone…
ADI launch seventh report in the ‘From Plan to Impact’ series
Alzheimer’s Disease International (ADI) has launched their seventh report in their ‘From Plan to Impact’ series, which tracks the progress of WHO Member States towards achieving the targets of the Global Action Plan on the public health response to dementia. This report looks at progress towards the targets of the Global Action Plan, highlighting the…
TIDE’s £1000 for 1000 carers campaign
Dementia carer charity TIDE (Together in Dementia Everyday) have launched £1000 for 1000, a new campaign with the aim of recruiting 1000 new carer members in 2024. Every TIDE member has free access to the TIDE network, online events, information and advice. The funds raised during this campaign will go towards the continuation of these…
1.6 million brain scans to be analysed under SCAN-DAN Project
Permission has been granted for researchers from the universities of Edinburgh and Dundee to use artificial intelligence (AI) to analyse 1.6 million brain scans for patterns that indicate the signs of dementia. NHS Scotland granted access to the anonymised CT and MRI images which were collected during routine clinical care between 2008 and 2018. The…
Cambridge University team receive funding to develop neurotechnologies for dementia
A partnership of people from the health, science and business sectors in Cambridge is collaborating with the Advanced Research and Invention Agency (ARIA – the UK government’s new research funding agency) to create new neurotechnologies, including brain implants that could treat dementia. The 3-year partnership between the University of Cambridge and ARIA is intended to…
A trio of ‘Knowledge is Power’ resources available
Innovations in dementia have launched their England edition of their ‘Knowledge is Power’ post-diagnostic support resource. The booklet, like the Scotland and Wales editions, is written by people living with dementia for people living with dementia and contains a wealth of information, resources, and support for anyone with dementia and people around them. You can…

